268 related articles for article (PubMed ID: 17008694)
1. Processes to activate phase III clinical trials in a Cooperative Oncology Group: the Case of Cancer and Leukemia Group B.
Dilts DM; Sandler AB; Baker M; Cheng SK; George SL; Karas KS; McGuire S; Menon GS; Reusch J; Sawyer D; Scoggins M; Wu A; Zhou K; Schilsky RL;
J Clin Oncol; 2006 Oct; 24(28):4553-7. PubMed ID: 17008694
[TBL] [Abstract][Full Text] [Related]
2. Processes to activate phase III clinical trials in a cooperative oncology group: the elephant is monstrous.
Steensma DP
J Clin Oncol; 2007 Mar; 25(9):1148; author reply 1148-9. PubMed ID: 17369584
[No Abstract] [Full Text] [Related]
3. Invisible barriers to clinical trials: the impact of structural, infrastructural, and procedural barriers to opening oncology clinical trials.
Dilts DM; Sandler AB
J Clin Oncol; 2006 Oct; 24(28):4545-52. PubMed ID: 17008693
[TBL] [Abstract][Full Text] [Related]
4. Development of clinical trials in a cooperative group setting: the eastern cooperative oncology group.
Dilts DM; Sandler A; Cheng S; Crites J; Ferranti L; Wu A; Gray R; MacDonald J; Marinucci D; Comis R
Clin Cancer Res; 2008 Jun; 14(11):3427-33. PubMed ID: 18519773
[TBL] [Abstract][Full Text] [Related]
5. The cancer and leukemia group B pharmacology and experimental therapeutics committee: a historical perspective.
Ratain MJ; Miller AA; McLeod HL; Venook AP; Egorin MJ; Schilsky RL
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3612s-6s. PubMed ID: 16740794
[TBL] [Abstract][Full Text] [Related]
6. Time to activate lung cancer clinical trials and patient enrollment: a representative comparison study between two academic centers across the atlantic.
Wang-Gillam A; Williams K; Novello S; Gao F; Scagliotti GV; Govindan R
J Clin Oncol; 2010 Aug; 28(24):3803-7. PubMed ID: 20644091
[TBL] [Abstract][Full Text] [Related]
7. Steps and time to process clinical trials at the Cancer Therapy Evaluation Program.
Dilts DM; Sandler AB; Cheng SK; Crites JS; Ferranti LB; Wu AY; Finnigan S; Friedman S; Mooney M; Abrams J
J Clin Oncol; 2009 Apr; 27(11):1761-6. PubMed ID: 19255315
[TBL] [Abstract][Full Text] [Related]
8. Cancer and Leukemia Group B (CALGB).
Kornblith AB
J Natl Cancer Inst Monogr; 1996; (20):67-71. PubMed ID: 8750469
[No Abstract] [Full Text] [Related]
9. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
10. A concise history of the cancer and leukemia group B.
Schilsky RL; McIntyre OR; Holland JF; Frei E
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3553s-5s. PubMed ID: 16740784
[TBL] [Abstract][Full Text] [Related]
11. The cancer and leukemia group B oncology nursing committee (1983-2006): a history of passion, commitment, challenge, and accomplishment.
Smith EL; Skosey C; Armer J; Berg D; Cirrincione C; Henggeler M
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3638s-41s. PubMed ID: 16740799
[TBL] [Abstract][Full Text] [Related]
12. An essential partnership: patient advocates and cooperative groups.
Collyar D
Semin Oncol; 2008 Oct; 35(5):553-5. PubMed ID: 18929153
[TBL] [Abstract][Full Text] [Related]
13. Development of cancer cooperative groups in Japan.
Fukuda H
Jpn J Clin Oncol; 2010 Sep; 40(9):881-90. PubMed ID: 20670961
[TBL] [Abstract][Full Text] [Related]
14. Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.
Kimmick GG; Peterson BL; Kornblith AB; Mandelblatt J; Johnson JL; Wheeler J; Heinze R; Cohen HJ; Muss HB
J Clin Oncol; 2005 Apr; 23(10):2201-7. PubMed ID: 15800312
[TBL] [Abstract][Full Text] [Related]
15. Adapting clinical trials networks to promote cancer prevention and control research.
Weiner BJ; McKinney MM; Carpenter WR
Cancer; 2006 Jan; 106(1):180-7. PubMed ID: 16333855
[TBL] [Abstract][Full Text] [Related]
16. The cancer and leukemia group B cancer in the elderly committee: addressing a major cancer need.
Cohen HJ; Muss HB
Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3606s-11s. PubMed ID: 16740793
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the informed consent process for randomized clinical trials in pediatric and adult oncology.
Simon CM; Siminoff LA; Kodish ED; Burant C
J Clin Oncol; 2004 Jul; 22(13):2708-17. PubMed ID: 15226338
[TBL] [Abstract][Full Text] [Related]
18. Interim futility analysis with intermediate endpoints.
Goldman B; LeBlanc M; Crowley J
Clin Trials; 2008; 5(1):14-22. PubMed ID: 18283075
[TBL] [Abstract][Full Text] [Related]
19. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
[TBL] [Abstract][Full Text] [Related]
20. Quality-of-life research in the Pediatric Oncology Group: 1991-1995.
Bradlyn AS; Pollock BH
J Natl Cancer Inst Monogr; 1996; (20):49-53. PubMed ID: 8750466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
